DE3787002D1 - Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen. - Google Patents
Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen.Info
- Publication number
- DE3787002D1 DE3787002D1 DE8787311391T DE3787002T DE3787002D1 DE 3787002 D1 DE3787002 D1 DE 3787002D1 DE 8787311391 T DE8787311391 T DE 8787311391T DE 3787002 T DE3787002 T DE 3787002T DE 3787002 D1 DE3787002 D1 DE 3787002D1
- Authority
- DE
- Germany
- Prior art keywords
- proteins
- synthetic peptides
- immunity against
- cellular immunity
- aids virus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 241000700605 Viruses Species 0.000 title 1
- 230000007969 cellular immunity Effects 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US94793586A | 1986-12-30 | 1986-12-30 | |
US1443087A | 1987-02-12 | 1987-02-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE3787002D1 true DE3787002D1 (de) | 1993-09-16 |
DE3787002T2 DE3787002T2 (de) | 1993-11-25 |
Family
ID=26686083
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE87311391T Expired - Lifetime DE3787002T2 (de) | 1986-12-30 | 1987-12-23 | Synthetische Peptide, die zelluläre Immunität gegen den AIDS-Virus und dessen Proteine erzeugen. |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0273716B1 (de) |
JP (1) | JPH0762031B2 (de) |
AU (1) | AU592258B2 (de) |
CA (1) | CA1340896C (de) |
DE (1) | DE3787002T2 (de) |
IL (1) | IL84980A (de) |
WO (1) | WO1988005051A1 (de) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ221440A (en) * | 1986-08-20 | 1991-11-26 | Genetic Systems Corp | Composition containing monoclonal antibodies/peptides useful in treating and diagnosing hiv infections |
US5166050A (en) * | 1986-08-20 | 1992-11-24 | Bristol-Myers Squibb Company | Monoclonal antibodies and peptides useful in treating and diagnosing HIV infections |
US5976541A (en) * | 1988-01-26 | 1999-11-02 | The United States Of America As Represented By The Department Of Health And Human Services | Potent peptide for stimulation of cytotoxic T lymphocytes specific for the HIV-1 envelope |
US5939074A (en) * | 1986-12-30 | 1999-08-17 | The United States Of America As Represented By The Department Of Health And Human Services | Multideterminant peptide antigens |
US5030449A (en) * | 1988-07-21 | 1991-07-09 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Synthetic vaccine against AIDS virus |
EP0279688B1 (de) * | 1987-02-20 | 1997-04-16 | Genentech, Inc. | Verfahren und Zubereitungen für die Verwendung von HIV-env-Polypeptiden und Antikörpern |
AU2914889A (en) * | 1987-08-28 | 1989-04-17 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US5128319A (en) * | 1987-08-28 | 1992-07-07 | Board Of Regents, The University Of Texas System | Prophylaxis and therapy of acquired immunodeficiency syndrome |
US6210873B1 (en) | 1987-08-28 | 2001-04-03 | Board Of Regents, The University Of Texas System | Methods and compositions for the priming of specific cytotoxic T-lymphocyte response |
US5820865A (en) * | 1988-01-26 | 1998-10-13 | The United States Of America As Represented By The Department Of Health And Human Services | Method to induce cytotoxic T Lymphocytes specific for a broad array of HIV-1 isolates using hybrid synthetic peptides |
EP0400076B1 (de) * | 1988-01-26 | 1996-05-15 | THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce | Synthetisches antigen zum bewirken einer anti-hiv-reaktion |
US5763160A (en) * | 1988-02-12 | 1998-06-09 | United Biomedical, Inc. | Synthetic peptides and process of using same for the detection of antibodies to human immunodeficiency virus (HIV) gp120 envelope protein, diagnosis of AIDS and pre-AIDS conditions and as vaccines |
CA1341285C (en) * | 1988-02-12 | 2001-08-14 | Chang Yi Wang | Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines |
US5562905A (en) * | 1988-04-26 | 1996-10-08 | E. I. Du Pont De Nemours And Company | Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals |
US5185147A (en) * | 1988-08-19 | 1993-02-09 | Cellular Products, Inc. | Short polypeptide sequences useful in the production and detection of antibodies against human immunodeficiency virus |
EP0362909A3 (de) * | 1988-08-26 | 1990-11-14 | Akzo N.V. | Synthetische Polypeptide, immunochemisch aktiv mit HIV-Antikörpern |
WO1990003984A1 (en) * | 1988-10-03 | 1990-04-19 | Repligen Corporation | Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
FR2640877A1 (de) * | 1988-12-06 | 1990-06-29 | Centre Nat Rech Scient | |
GB8910145D0 (en) * | 1989-05-03 | 1989-06-21 | Connaught Lab | Synthetic peptides for an hiv-1 vaccine |
CA2025634A1 (en) * | 1989-09-19 | 1991-03-20 | Thomas Fuerst | Peptides including ctl epitopes of hiv proteins and use thereof |
EP0493508A1 (de) * | 1989-09-22 | 1992-07-08 | Idec Pharmaceuticals Corporation | Von der cd4-bindungsregion des gp120 abgeleitete neue peptide und die art ihrer verwendung |
NZ235538A (en) * | 1989-10-12 | 1992-06-25 | Viral Technologies Inc | Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera |
US5346989A (en) * | 1990-08-22 | 1994-09-13 | Syntello Vaccine Development Kb | Peptides for use in induction of T cell activation against HIV-1 |
AU662534B2 (en) * | 1991-06-03 | 1995-09-07 | Syntello Vaccine Development Ab | Peptides for use in induction of T cell activation against HIV-1 |
FR2677654B1 (fr) * | 1991-06-17 | 1995-11-17 | Pasteur Merieux Serums Vacc | Composes a effet immunogene anti-cytokine, a effet immunogene anticytostatique ou a effet vaccinal anti-infection a hiv. |
ES2257733T3 (es) * | 1991-08-29 | 2006-08-01 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Antigenos peptidicos multideterminantes que estimulan la respuesta de los linfocitos auxiliares al hiv en una amplia gama de humanos. |
WO1993015750A1 (en) * | 1992-02-10 | 1993-08-19 | Haynes Barton F | Use of synthetic peptides to induce tolerance to pathogenic t and b cell epitopes of autoantigens |
US5556744A (en) * | 1992-05-29 | 1996-09-17 | The Trustees Of The University Of Pennsylvania | Methods and compositions for diagnosing and treating certain HIV infected patients |
US5607914A (en) * | 1993-01-13 | 1997-03-04 | Pioneer Hi-Bred International, Inc. | Synthetic antimicrobial peptides |
US6479055B1 (en) | 1993-06-07 | 2002-11-12 | Trimeris, Inc. | Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
US5603933A (en) * | 1993-08-31 | 1997-02-18 | Board Of Regents, The University Of Texas | CD4 peptides for binding to viral envelope proteins |
DE4405810A1 (de) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Von einem Retrovirus aus der HIV-Gruppe abgeleitete Peptide und deren Verwendung |
AU715731B2 (en) * | 1994-10-20 | 2000-02-10 | Institut Pasteur | Nucleotide sequences of HIV-1 group (or subtype) O retrovirus antigens |
US5714577A (en) * | 1996-01-26 | 1998-02-03 | University Of Pittsburgh | Antimicrobial peptides |
WO2000076537A2 (en) * | 1997-09-10 | 2000-12-21 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of semi-allogeneic cell line-peptide complexes for the treatment of cancer, aids and other viral diseases |
US6749856B1 (en) | 1997-09-11 | 2004-06-15 | The United States Of America, As Represented By The Department Of Health And Human Services | Mucosal cytotoxic T lymphocyte responses |
CN1230444C (zh) | 1998-11-16 | 2005-12-07 | 德克萨斯州立大学董事会 | 含有hiv细胞毒t淋巴细胞表位的hiv多肽或肽或其多聚核苷酸表达构建体的用途 |
WO2000058438A2 (en) * | 1999-03-29 | 2000-10-05 | David Bernstein | Conformationally constrained peptides |
IL150961A0 (en) * | 2000-02-04 | 2003-02-12 | Univ Duke | Human immunodeficiency virus vaccine |
JP4419549B2 (ja) | 2003-07-18 | 2010-02-24 | 東レ株式会社 | 極細短繊維不織布および皮革様シート状物ならびにそれらの製造方法 |
JP2008535783A (ja) | 2005-02-15 | 2008-09-04 | サイモン・エル・エル・シー | Hiv−1の増殖を弱めるための方法および組成物 |
WO2009012143A2 (en) | 2007-07-13 | 2009-01-22 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Virus derived antimicrobial peptides |
US9399663B2 (en) * | 2014-02-24 | 2016-07-26 | Georgetown University | Competitive inhibitor of GP120 |
WO2021092382A1 (en) | 2019-11-08 | 2021-05-14 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compositions comprising antimicrobial peptides |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4554101A (en) * | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
US4689398A (en) * | 1984-06-20 | 1987-08-25 | Ortho Diagnostic Systems Inc. | HTLV test using synthetic peptides |
ATE71150T1 (de) * | 1984-09-19 | 1992-01-15 | Univ California | Retrovirale polypeptide in zusammenhang mit menschlicher transformation. |
PT81338B (pt) * | 1984-10-18 | 1987-11-11 | Pasteur Institut | Antigenios, em especial antigenios do envolucro do virus de linfoadenopatias e do sindroma de imuno-deficiencia adquirido, e virus, processo para a producao de antigenios do envolucro do virus, utilizacao destes antigenios na preparacao de composicoes imunogenicas ou no diagnostico da presenca de anticorpos contra este virus |
NZ213823A (en) * | 1984-10-26 | 1988-05-30 | Us Health | Producing human t-cell leukemia retrovirus envelope protein fragments in bacteria |
US4629783A (en) * | 1985-04-29 | 1986-12-16 | Genetic Systems Corporation | Synthetic antigen for the detection of AIDS-related disease |
-
1987
- 1987-12-23 JP JP63502098A patent/JPH0762031B2/ja not_active Expired - Fee Related
- 1987-12-23 EP EP87311391A patent/EP0273716B1/de not_active Expired - Lifetime
- 1987-12-23 AU AU13657/88A patent/AU592258B2/en not_active Expired
- 1987-12-23 DE DE87311391T patent/DE3787002T2/de not_active Expired - Lifetime
- 1987-12-23 WO PCT/US1987/003471 patent/WO1988005051A1/en unknown
- 1987-12-29 CA CA000555480A patent/CA1340896C/en not_active Expired - Fee Related
- 1987-12-29 IL IL84980A patent/IL84980A/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE3787002T2 (de) | 1993-11-25 |
EP0273716A2 (de) | 1988-07-06 |
CA1340896C (en) | 2000-02-15 |
AU592258B2 (en) | 1990-01-04 |
IL84980A0 (en) | 1988-06-30 |
JPS63503227A (ja) | 1988-11-24 |
WO1988005051A1 (en) | 1988-07-14 |
JPH0762031B2 (ja) | 1995-07-05 |
EP0273716B1 (de) | 1993-08-11 |
EP0273716A3 (en) | 1989-12-20 |
AU1365788A (en) | 1988-07-27 |
IL84980A (en) | 1993-06-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE3787002D1 (de) | Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen. | |
NL192275B (nl) | Eiwit van het AIDS-virus. | |
FR2681326B1 (fr) | Nouveaux derives peptidiques, leur preparation et leur utilisation comme medicaments. | |
NL300249I1 (nl) | Cefalosporinen en homologen, bereidingen en farmaceutische preparaten. | |
NL194578B (nl) | Farmaceutisch preparaat met cyclosporine. | |
DE69020039D1 (de) | Azlakton-Pfropfcopolymere. | |
DK0538300T3 (da) | O-Glycosyleret IFN-alfa | |
EP0269712A4 (de) | An der pathogenese einer hiv-infektion beteiligte peptide. | |
DE69018647D1 (de) | Arzneimittel. | |
FI915160A0 (fi) | Polymermjukningsmedel foer polyvinylklorid. | |
DE69534778D1 (en) | Cathepsin-02-protease | |
NL195028B (nl) | Cyclosporinebevattend farmaceutisch preparaat. | |
ZA9610721B (en) | Grapevine leafroll virus proteins and their uses. | |
MX9201681A (es) | 4,5-dihidro-1h-pirazol-1-carboxiamidas 3,4,n-sustituidas y su uso como inseticidas. | |
DE68910577D1 (de) | Mittel gegen den AIDS-Virus. | |
DE69206280D1 (de) | Succinimid enthaltende Polymere und von diesen hergestellte Latices. | |
IT8819417A0 (it) | Sussidio chirurgico ad azione osteotropa. | |
EA200000875A1 (ru) | Белки, взаимодействующие с каспазой-8 | |
FI904357A0 (fi) | Foerfarande foer aktivering av protein c. | |
ATE92934T1 (de) | Synthetische peptide, die zellulaere immunitaet gegen den aids-virus und dessen proteine erzeugen. | |
DE68906245D1 (de) | Therapeutisches mittel gegen aids. | |
ZA9610510B (en) | Novel peptides, the preparation and use thereof. | |
NL194918B (nl) | SDK-peptide, en therapeutische preparaten die deze bevatten. | |
MX9203757A (es) | Derivado de eritromicina y la preparacion y uso del mismo. | |
FR2670116B1 (fr) | Electrode, notamment electrode temporaire pour le cóoeur. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |